These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
57 related items for PubMed ID: 16857827
21. Promoting reactive oxygen species accumulation to overcome tyrosine kinase inhibitor resistance in cancer. Lin W, Wang X, Diao M, Wang Y, Zhao R, Chen J, Liao Y, Long Q, Meng Y. Cancer Cell Int; 2024 Jul 09; 24(1):239. PubMed ID: 38982494 [Abstract] [Full Text] [Related]
22. Sequential chemotherapy and icotinib as first-line treatment for advanced epidermal growth factor receptor-mutated non-small cell lung cancer. Sun SJ, Han JD, Liu W, Wu ZY, Zhao X, Yan X, Jiao SC, Fang J. World J Clin Cases; 2022 Jun 26; 10(18):6069-6081. PubMed ID: 35949840 [Abstract] [Full Text] [Related]
23. Mining Natural Compounds to Target WNT Signaling: Land and Sea Tales. Katanaev VL, Blagodatski A, Xu J, Khotimchenko Y, Koval A. Handb Exp Pharmacol; 2021 Jun 26; 269():215-248. PubMed ID: 34455487 [Abstract] [Full Text] [Related]
24. A phase I/II trial of weekly nab-paclitaxel for pretreated non-small-cell lung cancer patients without epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement. Harada D, Kozuki T, Nogami N, Bessho A, Hosokawa S, Fukamatsu N, Hotta K, Ohashi K, Kubo T, Yoshioka H, Yokoyama T, Sone N, Kuyama S, Kudo K, Yasugi M, Takigawa N, Oze I, Kiura K. Asia Pac J Clin Oncol; 2019 Aug 26; 15(4):250-256. PubMed ID: 30938103 [Abstract] [Full Text] [Related]